It is possible new templates exist for this target since these models were created.
Available Structures
57 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal Structure of the SR12813-bound PXR/RXRalpha LBD Heterotetramer Complex |
Heteromer P19793; Q15788; | 2×SRL; | ||||
| Assess | ||||||
| Crystal Structure of PXR LBD Complexed with SJB7 |
Heteromer Q15788; | 2×4WH; | ||||
| Assess | ||||||
| Crystal Structure of the apo-PXR/RXRalpha LBD Heterotetramer Complex |
Heteromer P19793; | 2×MG; | ||||
| Assess | ||||||
| Crystal Structure of the human PXR-LBD in complex with an SRC-1 coactivator peptide and SR12813 |
Heteromer Q15788; | 1×SRL; | ||||
| Assess | ||||||
| Structure of pregnane X receptor in complex with a Sphingosine 1- Phosphate Receptor 1 Antagonist |
Heteromer Q15788; | 2×D7E; | ||||
| Assess | ||||||
| Crystal Structure of the Human Pregnane X Receptor LBD in complex with an SRC-1 coactivator peptide… |
Heteromer P70365; | 1×444; | ||||
| Assess | ||||||
| Crystal structure of pregnane X receptor ligand binding domain complexed with JQ1 |
Heteromer Q15788; | 2×JQ1; | ||||
| Assess | ||||||
| STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN BOUND WITH ADNECTIN-1 AND COMPOUND-1 |
Heteromer | 2×40U; | ||||
| Assess | ||||||
| STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN with ADNECTIN-1 |
Heteromer | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF PXR IN COMPLEX WITH XPC-7455 | homo-2-mer | 2×KUB; | ||||
| Assess | ||||||
| STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN BOUND TETHERED WITH SRC CO-ACTIVATOR P… | homo-2-mer | 2×L7D; | ||||
| Assess | ||||||
| Crystal structure of the hPXR-LBD in complex with the synthetic estrogen 17alpha-ethinylestradiol | homo-2-mer | 2×3WF; 4×MPD; | ||||
| Assess | ||||||
| Crystal structure of the human PXR ligand-binding domain in complex with sclareol | homo-2-mer | 2×UK6; 2×GOL; | ||||
| Assess | ||||||
| The structure of human pregnane X receptor in complex with an SRC-1 coactivator peptide and a limon… | homo-2-mer | 2×G3L; | ||||
| Assess | ||||||
| Crystal structure of the hPXR-LBD in complex with the synthetic estrogen 17alpha-ethinylestradiol a… | homo-2-mer | 2×3WF; 2×3WG; 2×MPD; 2×IPA; | ||||
| Assess | ||||||
| Tethered PXR-LBD/SRC-1p bound to Garcinoic Acid | homo-2-mer | 2×NQD; 3×DMS; | ||||
| Assess | ||||||
| Crystal structure of pregnane X receptor ligand binding domain complexed with T0901317 analog T0-C6 | homo-2-mer | 2×WQB; | ||||
| Assess | ||||||
| STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN BOUND TETHERED WITH SRC co-activator p… | homo-2-mer | 2×XGH; | ||||
| Assess | ||||||
| Crystal structure of the hPXR-LBD obtained in presence of the pesticide trans-nonachlor | homo-2-mer | 2×IPA; 2×MPD; | ||||
| Assess | ||||||
| Crystal Structure of the Pregnane X Receptor bound to Colupulone | homo-2-mer | 2×CDZ; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF PXR IN COMPLEX WITH COMPOUND 7 | homo-2-mer | 1×HCJ; | ||||
| Assess | ||||||
| Crystal structure of the hPXR-LBD in complex with oxadiazon | monomer | 1×GOL; 1×S6Z; 1×IPA; | ||||
| Assess | ||||||
| Crystal structure of the human PXR ligand-binding domain in complex with liranaftate | monomer | 1×ULC; | ||||
| Assess | ||||||
| Crystal structure of hPXR in complex with dabrafenib | monomer | 1×P06; 1×IPA; | ||||
| Assess | ||||||
| Crystal structure of the hPXR-LBD in complex with pretilachlor | monomer | 2×S6T; 5×IPA; | ||||
| Assess | ||||||
| Crystal structure of the hPXR-LBD in complex with estradiol and heptachlor endo-epoxide | monomer | 1×EST; 1×S65; 1×MPD; | ||||
| Assess | ||||||
| Crystal structure of the hPXR-LBD in complex with alpha-zearalanol | monomer | 2×IPA; 1×MPD; 1×27J; | ||||
| Assess | ||||||
| PXR IN COMPLEX WITH THROMBIN INHIBITOR COMPOUND 17 | monomer | 2×GOL; 1×MPD; 1×PO4; | ||||
| Assess | ||||||
| Tethered PXR-LBD/SRC-1p apoprotein | monomer | |||||
| Assess | ||||||
| Crystal structure of the hPXR-LBD in complex with estradiol and endosulfan | monomer | 1×EST; 1×MPD; 1×S68; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of the hPXR-LBD in complex with ferutinine | monomer | 1×27H; 1×GOL; 4×IPA; | ||||
| Assess | ||||||
| human PXR LBD bound to GSK002 | monomer | 1×5YU; | ||||
| Assess | ||||||
| Tethered PXR-LBD/SRC-1p complexed with SR-12813 | monomer | 1×SRL; | ||||
| Assess | ||||||
| Crystal Structure of the Human Pregane X Receptor Ligand Binding Domain in Complex with Hyperforin,… | monomer | 1×HYF; | ||||
| Assess | ||||||
| Crystal structure of the hPXR-LBD in apo form (P43212 SG) | monomer | 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of the hPXR-LBD in complex with estradiol and cis-chlordane | monomer | 1×EST; 1×MPD; 1×S6E; 1×S6H; 1×IPA; | ||||
| Assess | ||||||
| Crystal structure of pregnane X receptor ligand binding domain complexed with T0901317 analog SJPYT… | monomer | 1×X1D; | ||||
| Assess | ||||||
| human PXR LBD bound to GSK001 | monomer | 1×P06; | ||||
| Assess | ||||||
| PXR in complex with P2X4 inhibitor compound 25 | monomer | 1×GOL; 3×DMS; | ||||
| Assess | ||||||
| Crystal structure of pregnane X receptor ligand binding domain complexed with rifamycin S | monomer | 1×VA0; | ||||
| Assess | ||||||
| Crystal structure of the hPXR-LBD in complex with cis-chlordane | monomer | 1×S6H; 3×IPA; 1×GOL; | ||||
| Assess | ||||||
| human PXR LBD bound to compound 2 | monomer | 1×07F; | ||||
| Assess | ||||||
| Crystal structure of the hPXR-LBD in complex with clotrimazole | monomer | 1×CL6; | ||||
| Assess | ||||||
| STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN BOUND TETHERED WITH SRC co-activator p… | monomer | 1×QCG; | ||||
| Assess | ||||||
| Crystal structure of pregnane X receptor ligand binding domain complexed with T0901317 analog T0-BP | monomer | 1×Y5B; | ||||
| Assess | ||||||
| Crystal structure of the hPXR-LBD in complex with estradiol and clotrimazole | monomer | 1×CL6; 1×EST; | ||||
| Assess | ||||||
| Crystal structure of the hPXR-LBD in complex with endosulfan | monomer | 1×MPD; 1×S68; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of the hPXR-LBD in complex with fipronil | monomer | 1×S6W; 5×IPA; | ||||
| Assess | ||||||
| Crystal structure of the hPXR-LBD in complex with tributyltin | monomer | 2×TBY; | ||||
| Assess | ||||||
| Crystal structure of the human PXR ligand-binding domain in complex with 2,2'-dichloro bisphenol A | monomer | 2×UAI; | ||||
| Assess | ||||||
| human PXR LBD bound to GSK003 | monomer | 1×5YX; | ||||
| Assess | ||||||
| STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN WITH COMPOUND-1 | monomer | 1×GOL; 1×40U; | ||||
| Assess | ||||||
| Crystal Structure of Apo Human Pregnane X Receptor Ligand Binding Domain | monomer | |||||
| Assess | ||||||
| Crystal Structure of Human Pregnane X Receptor Ligand Binding Domain Bound to SR12813 | monomer | 1×SRL; | ||||
| Assess | ||||||
| Activation of the Human Nuclear Xenobiotic Receptor PXR by the Reverse Transcriptase-Targeted Anti-… | monomer | 1×PNU; | ||||
| Assess | ||||||
| Crystal Structure Of the Human PXR-LBD In Complex With N-{(2R)-1-[(4S)-4-(4-chlorophenyl)-4-hydroxy… | monomer | 1×2Q4; 1×GOL; | ||||
| Assess | ||||||
| Structural Disorder in the Complex of Human PXR and the Macrolide Antibiotic Rifampicin | monomer | 1×RFP; | ||||
| Assess | ||||||
11 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7yfk.1.A | homo-2-mer | 0.81 | 2×G3L; | 100.00 | ||
| Assess | ||||||
| 7wnh.4.A | monomer | 0.56 | 1×ZN; | 25.83 | ||
| Assess | ||||||
| 4iqr.2.B | monomer | 0.56 | 2×ZN; | 26.10 | ||
| Assess | ||||||
| 3dzy.1.B | monomer | 0.55 | 1×ZN; | 26.65 | ||
| Assess | ||||||
| 7wnh.2.A | monomer | 0.55 | 2×ZN; | 25.83 | ||
| Assess | ||||||
| 4iqr.2.A | monomer | 0.54 | 2×ZN; | 26.10 | ||
| Assess | ||||||
| 3dzu.1.A | monomer | 0.54 | 2×ZN; | 24.54 | ||
| Assess | ||||||
| 5uan.1.A | monomer | 0.53 | 2×ZN; | 23.71 | ||
| Assess | ||||||
| 4nqa.2.A | monomer | 0.53 | 1×ZN; | 23.71 | ||
| Assess | ||||||
| 7prv.1.A | monomer | 0.50 | 2×ZN; | 20.06 | ||
| Assess | ||||||
| 7prw.1.B | monomer | 0.50 | 2×ZN; | 20.06 | ||
| Assess | ||||||